- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Abiraterone/prednisone
Total 2749 results
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Austria, Netherlands, Ireland, Hungary
-
Janssen Research & Development, LLCNo longer available
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
Universität des SaarlandesCompleted
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Australia, Spain, United Kingdom, Denmark, Belgium, Slovakia, Finland, Italy, France, Sweden
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Hoffmann-La RocheActive, not recruitingMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
BayerJanssen Research & Development, LLCCompletedProstatic NeoplasmsBelgium, Spain, Canada, United States, Japan, Russian Federation, France, Finland, Singapore, Australia, Germany, Israel, Netherlands, Norway, Italy, United Kingdom, Poland, Sweden, Brazil
-
Astex Pharmaceuticals, Inc.CompletedProstate CancerUnited States, United Kingdom, Spain, Canada
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Approved for marketingUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, MaleUnited States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Janssen Research & Development, LLCCompletedProstate CancerChina, Malaysia, Russian Federation, Thailand
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Nanjing University School of MedicineCompleted
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Hongqian GuoFirst Affiliated Hospital of Zhejiang University; Nanjing First Hospital, Nanjing... and other collaboratorsRecruitingNeoadjuvant TherapyChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
Janssen Research & Development, LLCTerminatedProstatic NeoplasmsUnited States, Canada
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
CelgeneCompletedSarcoidosis, PulmonaryUnited States, United Kingdom, Netherlands
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS)CompletedMyasthenia GravisThailand, Canada, Germany, Italy, Netherlands, Brazil, United States, Argentina, Australia, Chile, Japan, Mexico, Poland, Portugal, South Africa, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
Astellas Pharma Global Development, Inc.PfizerRecruitingProstate CancerUnited States, Korea, Republic of, Japan, Belgium, Spain, Argentina, Australia, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slov... and more
-
VA Office of Research and DevelopmentRecruitingRheumatoid ArthritisUnited States
-
Massachusetts General HospitalUnknown
-
West China HospitalNot yet recruitingProstatic Neoplasms, Castration-Resistant | Drug Therapy, CombinationChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Terminated
-
SanofiCompletedProstate CancerFrance, United Kingdom, United States
-
Curium US LLCActive, not recruitingMetastasis From Malignant Tumor of ProstateUnited States, France, Spain, Italy
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbWithdrawnMelanoma | Renal Cell Carcinoma | Lung CancerUnited States
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
University of California, San FranciscoMedical University of South Carolina; M.D. Anderson Cancer Center; University... and other collaboratorsEnrolling by invitationArterial Ischemic Stroke | Pediatric Stroke | ArteriopathyUnited States
-
Lawson Health Research InstituteCompletedAsthma ExacerbationCanada
-
Nagasaki UniversityUnknownEsophageal Anastomotic StrictureJapan
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Radboud University Medical CenterCompletedProstate CancerNetherlands
-
University of Southern CaliforniaNational Cancer Institute (NCI)UnknownRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Hongqian GuoAstraZeneca; Nanjing Chia-tai Tianqing PharmaceuticalRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate CarcinomaChina